|
National Stock Number(NSN): 6505-01-180-3221 (6505011803221, 011803221)
| NIIN: |
01-180-3221 |
Item Name: |
THEOPHYLLINE EXTENDED-RELEASE CAPSULES |
INC: |
42774
|
| FSC: |
6505
|
Assignment Date: |
May-26-1984 |
CRIT: |
N |
IIG: |
42774 |
| ISC: |
5 |
Date Standardized: |
May-26-1984 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Aug-01-2000 |
PMIC: |
A |
FIIG: |
A510U0 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
E |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
97 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
7-0499 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
NDC00067-0100-82 |
04518
|
AVENTIS PHARMACEUTICALS PRODUCTS INC. |
H |
5 |
9 |
|
|
|
|
|
|
|
|
|
NDC00075-0100-99 |
04518
|
AVENTIS PHARMACEUTICALS PRODUCTS INC. |
H |
3 |
2 |
4 |
KX |
|
|
|
|
|
|
|
SLO-BID |
04518
|
AVENTIS PHARMACEUTICALS PRODUCTS INC. |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
SLO-BID GYROCAPS |
04518
|
AVENTIS PHARMACEUTICALS PRODUCTS INC. |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
H |
Z |
M |
U |
1 |
A |
$47.44 |
BT |
|
C2201X- |
Oct-01-1999 |
H |
| DF |
S9M |
H |
|
M |
U |
1 |
F |
$47.44 |
BT |
|
------- |
Oct-01-1999 |
H |
| DN |
S9M |
H |
|
M |
U |
1 |
N |
$47.44 |
BT |
|
9L----- |
Oct-01-1999 |
H |
| DS |
S9M |
H |
|
M |
U |
1 |
D |
$47.44 |
BT |
|
------- |
Oct-01-1999 |
H |
| VA |
JVS |
I |
|
M |
U |
0 |
V |
$0.00 |
BT |
|
------- |
Jun-01-1989 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 1000EA |
000 |
|
|
|
| DA |
R |
REFER TO EDI ITEM |
000 |
|
|
|
| DF |
K |
U/I CONTAINS 1000EA |
000 |
|
|
|
| DF |
R |
REFER TO EDI ITEM |
000 |
|
|
|
| DN |
K |
U/I CONTAINS 1000EA |
000 |
|
|
|
| DN |
R |
REFER TO NON-STD NON-DMSB REV |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 1000EA |
000 |
|
|
|
| DS |
R |
REFER TO EDI ITEM |
000 |
|
|
|
| VA |
K |
U/I CONTAINS 1000EA |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
100.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT |
| AKJC |
CAPSULE TYPE |
ANY ACCEPTABLE |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CQLS |
CAPSULE CONTENT FORM |
ANY ACCEPTABLE |
| CYLZ |
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY |
1000.000 |
| ECWT |
EXTERIOR CONTAINER WEIGHT |
9.15 POUNDS |
| EXME |
EXTERIOR CONTAINER CUBIC MEASURE |
0.581 CUBIC FEET |
| EXQT |
EXTERIOR CONTAINER QUANTITY |
12 |
| FEAT |
SPECIAL FEATURES |
ANHYDROUS |
| SUCB |
UNIT OF ISSUE CUBE |
0.0484 CUBIC FEET |
| SUWT |
UNIT OF ISSUE WEIGHT |
0.76 POUNDS |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A111 |
|
Jul-18-1999 |
3 |
H |
|
|
|
|
| FSKX |
|
Jul-18-1999 |
3 |
H |
|
|
|
|
| N9LM |
|
Jul-18-1999 |
3 |
H |
|
|
|
|
| V542 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
|